Andrew J. Armanino - 29 Nov 2021 Form 4 Insider Report for Better Therapeutics, Inc.

Role
Director
Signature
/s/ Mark Heinen, Attorney-in-Fact
Issuer symbol
BTTX on OTC
Transactions as of
29 Nov 2021
Net transactions value
+$118,320
Form type
4
Filing time
01 Dec 2021, 15:42:58 UTC
Previous filing
04 Nov 2021
Next filing
15 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BTTX Common Stock Purchase $118,320 +17,000 +35% $6.96* 65,328 29 Nov 2021 By Armanino Trust F1, F2, F3
holding BTTX Common Stock 13,334 29 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.93 to $6.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 Reflects the correction of an immaterial error in Column 5 reported in the Reporting Person's Form 4 filed on November 1, 2021.
F3 These shares are owned directly by the Andrew J. Armanino III and Denise M. Armanino Family Trust (the "Armanino Trust"), and indirectly by the Reporting Person and his spouse, Denise M. Armanino, as trustees of the Armanino Trust.